ENXTPA:IVABiotechs
A Look At Inventiva (ENXTPA:IVA) Valuation After Weaker Full Year 2025 Earnings
Inventiva (ENXTPA:IVA) is in focus after reporting full year 2025 earnings, with sales of €4.48 million, a net loss of €354.14 million and a basic loss per share from continuing operations of €1.9.
See our latest analysis for Inventiva.
The earnings release appears to have weighed on sentiment in the short term, with a 30 day share price return of 12.48% and a 90 day share price return of 7.65%, even as the year to date share price return is 11.87% and the 1 year total shareholder return is...